Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Wed, 18 Oct 17 23:47:07 +0000 Wed, 18 Oct 17 23:47:07 +0000 FDA OKs Generic Emend Patients undergoing moderately emetogenic chemotherapy may use the product, in combination with other antiemetic medicines, for the prevention of delayed nausea and vomiting. Mon, 16 Oct 17 18:40:00 +0000 5 New FDA Approvals to Know from September 2017 Learn about the new products and expanded indications approved by the FDA in September 2017. Fri, 13 Oct 17 18:00:00 +0000 FDA OKs Pregabalin Extended-release Once-Daily Tablets for Neuropathic Pain The tablets did not get approval for managing fibromyalgia, however, according to a press release from Pfizer. Thu, 12 Oct 17 22:04:00 +0000 Key Points of President Trump's Health Care Executive Order The plan calls for sale of insurance across state lines.  Thu, 12 Oct 17 19:53:00 +0000 New Jersey Veterinarians Urged to Help Prevent Abuse of Pet Prescriptions Officials with the New Jersey Attorney General’s office are calling on veterinarians to help combat the opioid epidemic, announcing stricter guidelines aimed at preventing individuals from abusing prescription medications meant for their pets. Thu, 12 Oct 17 15:03:00 +0000 Pharmacists Sentenced in Prescription Drug Smuggling, Pill Mill Scheme Two pharmacists were recently sentenced for their roles in schemes involving smuggling misbranded prescription drugs and diverting opioid medications.  Thu, 12 Oct 17 12:00:00 +0000 Congress Urges Elimination of DIR Fees Several members of Congress recently sent a letter to the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) that urged the elimination of direct and indirect remuneration (DIR) fees.  Thu, 12 Oct 17 09:05:00 +0000 WHO Video Offers Tips for Safe Medication Practices Pharmacists may get more patient questions about medication safety, after a video on this subject aired on the World Health Organization’s (WHO) YouTube page. Wed, 11 Oct 17 20:51:00 +0000 Draft Recommendations Issued for Counseling on Sun Protection Draft recommendations are available for comment until November.  Wed, 11 Oct 17 18:38:00 +0000 FDA OKs Osteoarthritis Knee Pain Drug It is currently the first and only extended-release, intra-articular injection available for OA. Sun, 08 Oct 17 19:45:00 +0000 FDA Approves New Strength for Tardive Dyskinesia Drug FDA officials have approved an 80-mg capsule strength of Neurocrine Biosciences’ valbenazine (Ingrezza) for the treatment of adults with tardive dyskinesia (TD), the company announced in a press release Fri, 06 Oct 17 14:38:00 +0000 FDA Approves Zika Virus Blood Screening Test FDA officials have approved the first test for screening Zika virus in blood donations. Fri, 06 Oct 17 13:43:00 +0000 Patients Want to Interact with Their Pharmacists on Social Media Social media has become a crucial tool for organizations and businesses to interact with their customers and discuss the services they offer. Many Americans look to social media for recommendations and to build stronger relationships with the brands they use. Wed, 04 Oct 17 20:02:00 +0000 FDA OKs Third Indication for BOTOX Cosmetic FDA officials have approved onabotulinumtoxinA (BOTOX Cosmetic, Allergan) for its third indication for the temporary improvement in the appearance of moderate-to-severe forehead lines associated with frontalis muscle activity in adults. Wed, 04 Oct 17 12:00:00 +0000 FDA Officials Warn About Compounding Risk According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV). Tue, 03 Oct 17 21:22:00 +0000 More Than One-Third of Older Adults Use Sleep Medications Most older adults don’t talk to their health care provider about sleep difficulties, even though more than one-third reported using some type of medication to help them sleep at night, according to results from the National Poll on Healthy Aging. Tue, 03 Oct 17 15:30:00 +0000 FDA Approves New Fast-Acting Mealtime Insulin Officials with the FDA have approved fast-acting insulin aspart (Fiasp, Novo Nordisk) for the treatment of adults with diabetes. Fri, 29 Sep 17 15:38:00 +0000 New Search Tool Enables Better Access to Adverse Drug Reaction Information While the FAERS dashboard now offers stakeholders many more ways of searching for and organizing data on adverse events reported to the FDA for many drug and biologic products, there remain limitations to the data. Fri, 29 Sep 17 12:39:00 +0000 FDA Approves Drug for Certain Advanced or Metastatic Breast Cancers Officials with the FDA have approved abemaciclib (Verzenio, Eli Lilly), for the treatment of adults with certain advanced or metastatic breast cancer. Thu, 28 Sep 17 19:01:00 +0000 Humira Litigation Ends, Clearing Path to Biosimilar Launch The agreement requires Amgen to pay royalties to AbbVie for sales of the biosimilar, according to a press release. Thu, 28 Sep 17 18:46:00 +0000 FDA Approves Continuous Glucose Monitoring System for Diabetes Officials with the FDA have approved FreeStyle Libre Flash Glucose Monitoring System (Abbot Diabetes Care Inc.), the first continuous glucose monitoring system for adult patients that reduces the need for fingerstick testing. Wed, 27 Sep 17 21:17:00 +0000 Beauty Product Manufacturer to Cease Distribution of Unapproved Drugs A New Jersey company that sold injectable skin whitening and other beauty products has been ordered to stop selling and recall some of its products because they are unapproved new drugs that are potentially unsafe to consumers, according to the FDA's press release.  Tue, 26 Sep 17 21:16:00 +0000 STD Rates Hit Record High in United States The number of sexually transmitted diseases (STDs) reported in the United States has reached a record high. Tue, 26 Sep 17 20:34:00 +0000 Interpol, FDA Partnership Targets Illegal Web Pharmacies During Operation Pangea X, the FDA sent 13 warning letters to the operators of 401 websites. Tue, 26 Sep 17 05:26:00 +0000 FDA Rejects Abuse-Deterrent Oxycodone Officials with the FDA have rejected Intellipharmaceutics’ abuse-deterrent Oxycodone Hydrochloride Extended-Release Tablets (Rexista), the company announced in a press release. Mon, 25 Sep 17 17:59:00 +0000